Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4518821000168116 | Kabiven G19% Intralipid (soya oil 80 g / 2.053 L) injection, 400 mL chamber (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4518831000168118 | Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | Is a | Kabiven G19% Intralipid | true | Inferred relationship | Some | ||
| Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | Is a | soya oil 80 g/2.053 L injection, 400 mL chamber | true | Inferred relationship | Some | ||
| Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | has unit of use | chamber | true | Inferred relationship | Some | 773816715 | |
| Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | has intended active ingredient | soya oil | true | Inferred relationship | Some | 2123355415 | |
| Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | has Australian BoSS | soya oil | true | Inferred relationship | Some | 2123355415 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | has TPUU | True | Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | Inferred relationship | Some | 902764189 |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 2.053 L multi-chamber bag | has TPUU | True | Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | Inferred relationship | Some | 781778485 |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 2.053 L multi-chamber bag | has TPUU | True | Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | Inferred relationship | Some | 1182064633 |
| Kabiven G19% (1 x Glucose chamber, 1 x Vamin 18 Novum chamber, 1 x Intralipid chamber), 4 x 2.053 L multi-chamber bags | has TPUU | True | Kabiven G19% Intralipid 80 g/2.053 L injection, 400 mL chamber | Inferred relationship | Some | 1832678498 |
Reference Sets
Trade product unit of use reference set
FHIR